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Cytokines: Shared receptors, distinct functions
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That the signal transduction pathways used by the
cytokines IL-2 and IL-15 are identical would suggest that
these cytokines have redundant roles in lymphoid
development; instead, IL-2 is the guardian of thymus-
derived T-cell homeostasis, while interleukin-15
promotes extrathymic development of T and NK cells.
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The cytokine road map for lymphopoiesis is often a
difficult one to navigate. This is partly due to the fact that
cytokines function in myriad fashions, being involved in
the survival, proliferation, differentiation and homeostasis
of lymphoid cells. Moreover, these soluble mediators are a
critical means of communication for effective immune
responses, being used by lymphocytes to signal both to
each other and to non-lymphoid cells, such as
macrophages, epithelial cells and stromal elements. The
spectrum of cytokine activity on various subsets of lym-
phoid cells has been classically defined using in vitro
assays. However, defining the relevant biological conse-
quences of cytokine interactions with their specific recep-
tors in vivo remains a challenge.
The Janus family of tyrosine kinases (JAKs) and the
‘signal transducers and activators of transcription’
(STATs) are intracellular proteins that are sequentially
activated during cytokine receptor signaling. Because a
large number of cytokine receptors (more than 25) signal
via the somewhat limited panel of JAKs (four known) and
STATs (seven known), one major unresolved question is
how cytokine responses achieve their final biological
specificity. Cytokine responses could in theory be made
specific by each cytokine having its own unique receptor.
It appears, however, that the receptors for many cytokines
have instead evolved towards a situation in which particu-
lar receptor chains — such as the gp130 molecule, or the
common b and g chains, bc and gc — are shared amongst
different receptor complexes. In principle, this approach
would appear to limit specificity.
An extreme example of this is provided by the receptors
for interleukin-2 (IL-2) and IL-15 (Fig. 1). The IL-2 and
IL-15 receptors share two chains, IL-2Rb and gc, both of
which are members of the large cytokine receptor super-
family. The IL-2Rb–gc heterodimer forms the core sig-
naling complex, which associates with JAK1 and JAK3,
and activates STAT3 and STAT5. The downstream
events that follow ligand binding include the activation
of nuclear proteins, such as Myc and Fos, and the upreg-
ulation of Bcl-2 and Bcl-XL levels, leading to resistance
to apoptotic cell death and either enhanced survival or
proliferation [1]. 
IL-2 and IL-15 also each associate with a unique third
chain, IL-2Ra and IL-15Ra, respectively (Fig. 1). The a
chains are related and form a family distinct from the
cytokine receptor superfamily [2]. Moreover, as the a
chains have short cytoplasmic domains, they do not
appear to contribute directly to signal transduction. The
primary role of the a chains appears to be to aid the for-
mation of high-affinity receptor complexes, which bind
ligand under limiting physiological conditions [3]. In the
Figure 1
IL-2 and IL-15 receptors are trimeric complexes that have unique a
chains but a shared core consisting of the IL-2Rb (2b) and gc chains,
which signal through JAK1 and JAK3 and STAT3 and STAT5.
Although this receptor arrangement suggests that IL-2 and IL-15 might
have redundant roles, IL-2 is critical for maintaining peripheral
homeostasis of thymus-derived T cells, whereas IL-15 promotes
extrathymic T and NK cell development. This response specificity is
achieved through a combination of differential ligand production sites
and regulation of receptor a chain expression.
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absence of an a chain, the IL-2Rb–gc dimer can respond
to either IL-2 or IL-15, although the affinity of this
receptor is lower. Thus, functional IL-2 and IL-15 recep-
tors are trimeric in nature and distinct, whereas the sig-
naling cascades they initiate when activated appear to be
identical.
Although IL-2 and IL-15 show no obvious sequence
similarities, they stimulate a similar spectrum of biological
activities in vitro [2,4]. This is perhaps not surprising,
considering the components their receptors have in
common. The effects of IL-2 and IL-15 have been
demonstrated on the three major lymphoid cell types:
immunoglobulin-producing B cells, antigen-specific cyto-
toxic and helper T cells, and natural killer (NK) cells. IL-2
and IL-15 have been shown to stimulate the proliferation
of T, B and NK cells, to augment the cytotoxicity of T and
NK cells, to increase immunoglobulin secretion by B cells
and to provoke release of interferon-g from T and NK
cells. The sole difference between IL-2 and IL-15 in
these assays appears to be in the amount of cytokine
needed to elicit a response, which may relate to differen-
tial expression of the respective IL-2 and IL-15 receptor a
chains in the responding cell populations.
Do IL-2 and IL-15 have redundant functions in vivo?
Such redundancy could be important in allowing an
immune response to be sustained under diverse
conditions. Although IL-2 and IL-15 do appear to be
redundant, the question remains as to whether they have
unique roles in vivo. And if they do, how is their biological
specificity achieved? Two mechanisms that might con-
tribute to the specificity IL-2 and IL-15 responses can
readily be envisaged, the first involving ligand compart-
mentalization and the second regulation of IL-2Ra and
IL-15Ra production. The available data suggest that both
of these mechanisms may be relevant.
The distributions of IL-2-producing and IL-15-producing
cells are very different [5]. IL-2 is made exclusively by
activated T cells, whereas IL-15 is made by a wide variety
of cells, including bone marrow stromal cells, gut and skin
epithelia, macrophages and other cell types, but not by
activated T cells [4,6,7]. These observations would
suggest that IL-2 may have a limited role during T cell
responses, whereas IL-15 may be involved more generally
in multiple stages of lymphoid development and perhaps
also in the function of non-lymphoid cells. IL-2Ra and
IL-15Ra also appear to be expressed in different cell
types. For example, activated T cells make abundant IL-
2Ra, but exhibit very few IL-15-binding sites, whereas
liver cells express a high level of IL-15Ra mRNA but no
detectable IL-2Ra mRNA [2]. Together, these regulatory
mechanisms could provide the means to delimit IL-2 and
IL-15 responses, supporting the idea that IL-2 and IL-15
would not fully replace each other in vivo. 
The generation of ‘knockout’ mice in which specific
genes have been inactivated by targeted recombination
has helped to answer the central question of the
redundancy of IL-2 and IL-15. Although IL-2 has
classically been defined as a T-cell growth factor, mice
deficient in the IL-2 pathway — whether IL-2–/–, IL-
2Ra–/– or IL-2Rb–/– homozygotes — have apparently
normal thymic and peripheral T-cell development, ruling
out an essential role for IL-2 signaling in these processes
[3,8,9]. These mutant mice do, however, exhibit defects in
peripheral lymphoid homeostasis and show evidence of
inappropriate T-cell activation, lymphoid infiltration and
autoimmunity [3, 8–10]. 
These data suggest that one of the unique roles for IL-2
in-vivo involves the termination of T-cell responses, as
originally proposed by Lenardo (reviewed in [11]). In
particular, IL-2 is suggested to be involved in a process of
‘activation-induced cell death’, in which repeated T-cell
receptor triggering leads to a high local production of IL-2,
upregulation of the apoptosis-inducing Fas/FasL system
and subsequent apoptosis. How an absence of IL-2 per-
turbs this process is not clear, but it may modulate trans-
duction of the ‘death signal’ via Fas. Two additional
points should be emphasized. First, an absence of IL-2
appears to affect only thymus-derived T cells, as athymic
(nude) mice deficient in IL-2 or gc are free from disease
[8,10]. And second, the fact that this pathology is present
in IL-2–/– and IL-2Ra–/– mutant mice clearly shows that
IL-15, despite its broad distribution, cannot compensate
for the absence of IL-2. Thus, IL-2 plays an essential role
in peripheral T-cell homeostasis.
Extrathymic T-cell development has been best
documented for gut intraepithelial lymphocytes, which
comprise two distinct lineages, ‘thymus-dependent’ and
‘thymus-independent’ subsets, based on their different
phenotypic and functional attributes (reviewed in [12]).
The mechanisms that control thymus-dependent versus
thymus-independent lymphoid differentiation are unclear
and have been the subject of much debate. Recent studies
of IL-2Rb–/– mice by Suzuki et al. [13] suggest that IL-15
plays the paramount role in extrathymic lymphoid devel-
opment. First, IL-2Rb–/– mice completely lack NK cells,
whereas these cells are present in IL-2–/– mice [8]. The NK
defect in IL-2Rb–/– mice was not completely unexpected
in view of the many studies demonstrating the potent
ability of IL-15 to support NK differentiation in vitro (see
below). A second, more striking observation, was that IL-
2Rb–/– mice lack thymus-independent, but not thymus-
dependent, gut intraepithelial lymphocytes. These
observations clearly show that IL-15 has an essential in
vivo role in extrathymic T and NK cell development.
How might IL-2 and IL-15 support extrathymic lymphoid
development? And do IL-2 and IL-15 have distinct roles
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in this process? Although IL-2 can support the develop-
ment and proliferation of NK lineage cells in vitro, a
number of observations suggest that IL-2 may not sub-
serve this function in vivo. Thus, IL-2 is clearly not
required for NK differentiation in vivo, as functional NK
cells are present in IL-2–/– and RAG–/– mutant mice (which
lack mature T cells, the only source of IL-2). Further-
more, IL-2 only stimulates NK generation in vitro at high
concentrations [7], bringing into question whether these
levels could be achieved physiologically in vivo. And if IL-
2 were critical for NK development, activated T cells
should be found at the site of NK cell genesis, in the bone
marrow for example, but this has not been demonstrated.
IL-15, in contrast, appears more physiologically relevant to
extrathymic lymphocyte development. Thus, IL-15 is a
potent factor for NK differentiation, and can maintain NK
cells in vitro at picomolar concentrations  [14]. IL-15 can
effectively substitute for the bone marrow stromal
microenvironment for NK generation in vitro [15]. And as
mentioned previously, IL-15 is produced by the correct
cells and tissues — bone marrow stroma, macrophages,
and gut and skin epithelia — to play a physiologically
important role in NK cell development. In this context,
the constitutive expression of IL-15 by macrophages pro-
vides an elegant mechanism for maintaining NK cells in
their local microenvironment [6]; this would permit effi-
cient NK cell–macrophage interactions, which are critical
for the initiation of immune responses.
As for extrathymic T cell development, IL-15 has been
shown to act as a potent growth factor for gd T cells [16].
The finding that IL-2Rb–/– mice lack the thymus-inde-
pendent subset of gut intraepithelial lymphocytes, which
comprise both gd and ab T cells [12], would again suggest
that IL-15 has a major role in maintaining these cells in
vivo. IL-15 mRNA has been detected in the gut epithe-
lium of rats, whereas IL-2 mRNA has not been detected
in this tissue [17]. Finally, IL-2-deficient mice show no
defects in gut gd T cell development, or gd T cell devel-
opment at other sites, for that matter [8]. Taken together,
these observations support the view that IL-15 is essential
for driving extrathymic T and NK cell development and
for sustaining the innate immune system.
The observation that the IL-2 and IL-15 receptors have
common subunits strongly suggested that these two
cytokines have related functions in vivo. But although IL-2
and IL-15 are both essential for the maintenance of
lymphoid cells, they act on and regulate distinct target cell
populations, and appear to have inverse roles. Thus, IL-2
is required for homeostasis of thymic-derived T cells
through termination of antigen-specific responses, whereas
IL-15 appears essential for the survival and proliferation of
extrathymic T and NK cells. This specificity is achieved
by a combination of compartmentalization of cytokine
production and differential expression of the IL-2Ra and
IL-15Ra chains. The generation and analysis of IL-15 and
IL-15Ra mutant mice will surely refute or confirm these
hypotheses.
Acknowledgements
I thank D. Guy-Grand, B. Cuenod-Jabri, N. Cerf-Bensussan, F. Rieux-Laucat
and J. Peschon for their helpful discussions.
References
1. Rebollo A, Gomez J, Martinez-A C: Lessons from immunological,
biochemical and molecular pathways of the activation mediated
by IL-2 and IL-4. Adv Immunol 1996, 63:127-196.
2. Giri JG, Kumaki S, Ahdieh M, Friend DJ, Loomis A, Shanebeck K,
DuBose R, Cosman D, Park LS, Anderson DM: Identification and
cloning of a novel IL-15 binding protein that is structurally related
to the a chain of the IL-2 receptor. EMBO J 1995, 14:3654-3663.
3. Willerford DM, Chen J, Ferry JA, Davidson L, Ma A, Alt FW:
Interleukin-2 receptor a chain regulates the size and content of
the peripheral compartment. Immunity 1995, 3:521-530.
4. Tagaya Y, Burton JD, Miyamoto Y, Waldman TA: Identification of a
novel receptor/signal transduction pathway for IL-15/T in mast
cells. EMBO J 1996, 15:4928-4939.
5. Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S,
Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M, et al.:
Cloning of a T cell growth factor that interacts with the b chain of
the interleukin-2 receptor. Science 1994, 264:965-968.
6. Doherty TM, Seder RA, Sher A: Induction and regulation of IL-15
expression in murine macrophages. J Immunol 1996, 156:735-
741.
7. Mrozek E, Anderson P, Caligiuri MA: Role of interleukin-15 in the
development of human CD56+ natural killer cells from CD34+
hematopoiietic progenitor cells. Blood 1996, 87:2632-2640.
8. Schimpl A, Hünig T: Interkeukin-2 overexpression and deprivation:
consequences for lymphopoiesis and T cell function. In
Overexpression and Knockout of Cytokines in Transgenic Mice.
Academic Press; 1994:31-45.
9. Suzuki, H, Kündig TM, Furlonger C, Wakeham A, Timms E,
Matsuyama T, Schmits R, Simard JJ, Ohashi PS, Griesser H, et al.:
Deregulated T cell activation and autoimmunity in mice lacking
interleukin-2 receptor beta. Science 1995, 268:1472-1476.
10. Sharara LI, Andersson A, Guy-Grand D, Fischer A, DiSanto JP:
Deregulated TCRab T-cell population provokes extramedullary
hematopoiesis in common g chain deficient mice. Eur J Immunol
1997, 27:990-998.
11. Lenardo MJ: Fas and the art of lymphocyte maintenance. J Exp
Med 1996, 183:721-724.
12. Rocha B, Guy-Grand D, Vassalli P: Extrathymic T cell
differentiation. Curr Opin Immunol 1995, 7:235-242.
13. Suzuki H, Duncan GS, Takimoto H, Mak TW: Abnormal
development of intestinal intraepithelial lymphocytes and
peripheral NK cells in mice lacking the IL-2Rb chain. J Exp Med
1997, 185:499-505.
14. Carson WE, Fehniger TA, Haldar S, Eckhert K, Lindemann MJ, Lai C-
F, Croce CM, Baumann H, Caligiuri MA: A potential role for
interleukin-15 in the regulation of human natural killer cell
survival. J Clin Invest 1997, 99:937-943.
15. Puzanov IJ, Bennett M, Kumar V: IL-15 can substitute for the
marrow microenvironment in the differentiation of NK cells. J
Immunol 1996, 157:4282-4285.
16. Nishimura H, Hiromatsu K, Kobayashi N, Grabstein KH, Paxton R,
Sugamura K, Bluestone JA, Yoshikai Y: IL-15 is a novel growth
factor for murine gd T cells induced by Salmonella infection. J
Immunol 1996, 156:66--669.
17. Reinecker H-C, MacDermott RP, Mirau S, Dignass A, Podolsky DK:
Intestinal epithelial cells both express and respond to interleukin
15. Gastroenterology 1996, 111:1706-1713.
